DHS and Medical Alliance retool merger

Article

Texas healthcare services companies Diagnostic Health Services of Dallas and Medical Alliance of Irving have restructured the terms of their merger agreement, first announced in March (SCAN 3/3/99). The companies changed the deal in order to make

Texas healthcare services companies Diagnostic Health Services of Dallas and Medical Alliance of Irving have restructured the terms of their merger agreement, first announced in March (SCAN 3/3/99). The companies changed the deal in order to make it more acceptable to shareholders, who responded tepidly to the terms of the original agreement.

Under the new deal, DHS will be incorporated into Medical Alliance in a reverse merger, with DHS shareholders receiving 0.375 shares of Medical Alliance common stock for every share of DHS they own. The previous deal had Medical Alliance merging into DHS. The new agreement will reduce the number of outstanding shares in the newly merged company from 22.7 million shares to 12 million. This should have a positive effect on the new company’s earnings per share, according to Brad Hummel, CEO of DHS. Medical Alliance will also provide a $2 million bridge loan to DHS.

Other aspects of the agreement will remain the same. The new company will be called Medical Alliance and will trade on the NASDAQ stock exchange under the symbol MAII. The new company’s management team will be made up of executives from both firms.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.